"10.1371_journal.pone.0010929","plos one","2010-06-03T00:00:00Z","Radu O Minea; Corey M Helchowski; Samuel J Zidovetzki; Fritz K Costa; Stephen D Swenson; Francis S Markland","Department of Biochemistry and Molecular Biology and Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America","Conceived and designed the experiments: ROM SDS. Performed the experiments: ROM CMH SJZ FKC SDS. Analyzed the data: ROM CMH SDS FSM. Wrote the paper: ROM. Designed and produced recombinant VCN: ROM. Provided funding support: SDS FSM.","ROM, SDS, and FSM are co-founders of Aspis Biopharmaceutical, a startup company aimed at developing disintegrin-based diagnostic and therapeutic solutions. The Vicrostatin sequence and its method of production are protected by patent applications filed by the University of Southern California. Nonetheless, the authors of the manuscript confirm that these issues do not alter their adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the PLOS ONE guide for authors at http://www.plosone.org/static/policies.action#sharing.","2010","06","Radu O Minea","ROM",6,TRUE,2,5,4,1,TRUE,TRUE,FALSE,0,NA,FALSE
